Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6190502 | Cancer Treatment Reviews | 2014 | 32 Pages |
Abstract
In this review, we aim to summarize the clinical evidence of first line treatment strategy with EGFR TKI and discuss the potential options in the sequence of treatment in EGFR-mutant patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J. Remon, T. Morán, N. Reguart, M. Majem, E. Carcereny, P. Lianes,